Cleveland Biolabs (CBLI) Reports Q2 Loss of $1.12
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS: -2.14K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS: -2.14K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q2 EPS of ($1.12), versus ($1.53) reported last year. Revenue for the quarter came in at $329.9 million, versus $562.1 million reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
